Revolutionizing Alcohol Withdrawal: A Benzodiazepine-Free Approach
Decreased benzodiazepine use, with adverse effects to benzodiazepines currently being associated, such as sedation, falls, respiratory depression, agitation, delirium and increased mortality.
Imagine a world where alcohol withdrawal doesn't automatically mean heavy sedation and risky side effects. In this episode of the 'Addiction Medicine Journal Club', Drs. Sonya Del Tredici and John Keenan dive into a groundbreaking benzodiazepine-sparing protocol for alcohol withdrawal. They explore how this new approach can lead to better patient outcomes, with fewer adverse effects like sedation and respiratory issues.
The episode also sheds light on the long-term success of a primary-care based MAT clinic and the ongoing push to make methadone more accessible by deregulating it. But that's not all. The hosts also introduce us to the Laps2 and Cops2 scores, innovative EMR-driven formulas that help clinicians assess the medical complexity and severity of a patient's condition. These tools are game-changers, allowing for more tailored treatments that can significantly improve patient care.
By reducing benzodiazepine use, this protocol aims to minimize complications such as falls, delirium, and even increased mortality rates. Listeners will find the discussion on improved ICU admission and readmission rates particularly compelling, as it highlights the real-world benefits of this protocol. Whether you're a healthcare professional or someone keen on the latest in addiction medicine, this episode offers valuable insights that could transform your understanding and approach to treatment.
Tune in to learn how you can apply these cutting-edge strategies in your own practice or support system.